SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca
1 Jul 2022

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

(Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreeme...

US FDA lifts clinical hold on Oxford BioMedica partner's trial
14 Jun 2022

US FDA lifts clinical hold on Oxford BioMedica partner's trial

(Alliance News) - Oxford BioMedica PLC on Tuesday noted that the US Food & Drug Administration lifted the clinical hold on Homology Medicines Inc's ph...

Oxford Biomedica sees FDA lift clinical hold on Homology's HMI-102 trial
14 Jun 2022

Oxford Biomedica sees FDA lift clinical hold on Homology's HMI-102 trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Tuesday that the US Food and Drug Administration had notified Homology Medicin...

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing
1 Jun 2022

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, Ju...

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250
25 May 2022

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing t...

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth
22 Apr 2022

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and n...

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley
22 Apr 2022

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon: